Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls.

Majumder S, Raimondo M, Taylor WR, Yab TC, Berger CK, Dukek BA, Cao X, Foote PH, Wu CW, Devens ME, Mahoney DW, Smyrk TC, Pannala R, Chari ST, Vege SS, Topazian MD, Petersen BT, Levy MJ, Rajan E, Gleeson FC, Dayyeh BA, Nguyen CC, Faigel DO, Woodward TA, Wallace MB, Petersen G, Allawi HT, Lidgard GP, Kisiel JB, Ahlquist DA.

Clin Gastroenterol Hepatol. 2019 Jul 16. pii: S1542-3565(19)30750-5. doi: 10.1016/j.cgh.2019.07.017. [Epub ahead of print]

PMID:
31323382
2.

Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus.

Iyer PG, Taylor WR, Johnson ML, Lansing RL, Maixner KA, Yab TC, Simonson JA, Devens ME, Slettedahl SW, Mahoney DW, Berger CK, Foote PH, Smyrk TC, Wang KK, Wolfsen HC, Ahlquist DA.

Am J Gastroenterol. 2018 Aug;113(8):1156-1166. doi: 10.1038/s41395-018-0107-7. Epub 2018 Jun 12.

PMID:
29891853
3.

Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma.

Anderson BW, Suh YS, Choi B, Lee HJ, Yab TC, Taylor WR, Dukek BA, Berger CK, Cao X, Foote PH, Devens ME, Boardman LA, Kisiel JB, Mahoney DW, Slettedahl SW, Allawi HT, Lidgard GP, Smyrk TC, Yang HK, Ahlquist DA.

Clin Cancer Res. 2018 Nov 15;24(22):5724-5734. doi: 10.1158/1078-0432.CCR-17-3364. Epub 2018 May 29.

4.

Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study.

Cotter TG, Burger KN, Devens ME, Simonson JA, Lowrie KL, Heigh RI, Mahoney DW, Johnson DH, Ahlquist DA, Kisiel JB.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):614-621. doi: 10.1158/1055-9965.EPI-16-0800. Epub 2016 Dec 20.

5.

Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening.

Johnson DH, Kisiel JB, Burger KN, Mahoney DW, Devens ME, Ahlquist DA, Sweetser S.

Gastrointest Endosc. 2017 Mar;85(3):657-665.e1. doi: 10.1016/j.gie.2016.11.012. Epub 2016 Nov 21.

6.

Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People.

Redwood DG, Asay ED, Blake ID, Sacco PE, Christensen CM, Sacco FD, Tiesinga JJ, Devens ME, Alberts SR, Mahoney DW, Yab TC, Foote PH, Smyrk TC, Provost EM, Ahlquist DA.

Mayo Clin Proc. 2016 Jan;91(1):61-70. doi: 10.1016/j.mayocp.2015.10.008. Epub 2015 Oct 28.

7.

Endoscopic overestimation of colorectal polyp size.

Anderson BW, Smyrk TC, Anderson KS, Mahoney DW, Devens ME, Sweetser SR, Kisiel JB, Ahlquist DA.

Gastrointest Endosc. 2016 Jan;83(1):201-8. doi: 10.1016/j.gie.2015.06.058. Epub 2015 Aug 28.

PMID:
26318830
8.

Patient perceptions of stool DNA testing for pan-digestive cancer screening: a survey questionnaire.

Yang D, Hillman SL, Harris AM, Sinicrope PS, Devens ME, Ahlquist DA.

World J Gastroenterol. 2014 May 7;20(17):4972-9. doi: 10.3748/wjg.v20.i17.4972.

9.

Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL.

Ann Intern Med. 2008 Oct 7;149(7):441-50, W81.

10.

Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.

Limburg PJ, Devens ME, Harrington JJ, Diehl NN, Mahoney DW, Ahlquist DA.

Am J Gastroenterol. 2003 Oct;98(10):2299-305.

PMID:
14572583
11.

Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.

Limburg PJ, Ahlquist DA, Sandborn WJ, Mahoney DW, Devens ME, Harrington JJ, Zinsmeister AR.

Am J Gastroenterol. 2000 Oct;95(10):2831-7.

PMID:
11051356

Supplemental Content

Loading ...
Support Center